Platelet Dysfunction
Conditions
Brief summary
In this non-interventional multicentre, prospective, observational cohort study, the efficacy of desmopressin is evaluated in patients with platelet dysfunction due to acetylsalicylic acid or cox-1-inhibitors within the context of surgical procedures.
Interventions
DRUGdesmopressin
Sponsors
Ferring Pharmaceuticals
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pre-, peri- or postoperative treatment with a standard dose of desmopressin as a result of platelet dysfunction (disturbance of blood platelet function) due to treatment with acetylsalicylic acid or cox-1-inhibitor. * Decision on the therapy with MINIRIN parenteral 4 Microgram/ml solution for injection has already been made independently by the physician beforehand * The patients (≥ 18 years) have been informed about the non-interventional study and have given their written consent for participation
Exclusion criteria
* Participation in a clinical trial * Treatment with acetylsalicylic acid for cardiovascular indications
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in platelet function pre- and post-administration of desmopressin | From baseline up to 7 days | As measured by Platelet Function Analyzer (PFA) 100/200 |
Countries
Germany
Outcome results
None listed